covid19. COVID DISEASE
Conditions
Interventions
Intervention 1: Intervention group: Patients receiving 2green tea extract capsule that each one have 450 mlgr twice a day after lunch and after dinner + usual hospital medicine. Intervention 2: Contr
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 18 years old or above Written informed consent form COVID-19 diagnosis based on polymerase chain reaction (PCR) Willingness to participate in research study
Exclusion criteria
Exclusion criteria: Pregnancy or lactation Disseminated intravascular coagulation or any other types of coagulopathy Severe congestive heart failure by the specialist Other contraindications prescribed by the specialist Participation in any clinical trial within the past 30 days prior to enrollment in the present study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CRP. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit.;Erythrocyte Sedimentation Rate (ESR). Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit.;CBC. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Cell counter devices. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMojtaba Yousefi
Yasouj University of Medical Sciences
Outcome results
None listed